Chemical Characteristics of Platycodon grandiflorum and its Mechanism in Lung Cancer Treatment.
Treatment of Small Cell Lung Cancer with Lurbinectedin: A Review.
Rajput PS, Khan SR, Singh P, Chawla PA.
Anticancer Agents Med Chem. 2022;22(5):812-820. doi: 10.2174/1871520621666210706150057.
Impact of Lung Cancer Treatment on Cognitive Functioning.
van de Kamp HJ, Molder MT, Schulkes KJG, Stellingwerf M, van Elden LJR, van Lindert ASR, Hamaker ME.
Clin Lung Cancer. 2020 Mar;21(2):114-126.e3. doi: 10.1016/j.cllc.2019.06.006. Epub 2019 Jun 15.
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small-Cell Lung Cancer.
Haratani K, Hayashi H, Chiba Y, Kudo K, Yonesaka K, Kato R, Kaneda H, Hasegawa Y, Tanaka K, Takeda M, Nakagawa K.
JAMA Oncol. 2018 Mar 1;4(3):374-378. doi: 10.1001/jamaoncol.2017.2925.
Cancer prevention with rapamycin.
Blagosklonny MV.
Oncotarget. 2023 Apr 14;14:342-350. doi: 10.18632/oncotarget.28410.
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer.
Sands JM, Champiat S, Hummel HD, Paulson KG, Borghaei H, Alvarez JB, Carbone DP, Carlisle JW, Choudhury NJ, Clarke JM, Gadgeel SM, Izumi H, Navarro A, Lau SCM, Lammers PE, Huang S, Hamidi A, Mukherjee S, Owonikoko TK.
Cancer. 2025 Feb 1;131(3):e35738. doi: 10.1002/cncr.35738.
Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2.
Horton BL, D'Souza AD, Zagorulya M, McCreery CV, Abhiraman GC, Picton L, Sheen A, Agarwal Y, Momin N, Wittrup KD, White FM, Garcia KC, Spranger S.
JCI Insight. 2023 Oct 9;8(19):e172728. doi: 10.1172/jci.insight.172728.
Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment.
Masago K, Fujita S.
J Thorac Oncol. 2022 Jan;17(1):16-18. doi: 10.1016/j.jtho.2021.10.002.
Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer: Benefits and Pulmonary Toxicities.
Suresh K, Naidoo J, Lin CT, Danoff S.
Chest. 2018 Dec;154(6):1416-1423. doi: 10.1016/j.chest.2018.08.1048. Epub 2018 Sep 4.
Pulmonary toxicity of systemic lung cancer therapy.
Long K, Suresh K.
Respirology. 2020 Nov;25 Suppl 2:72-79. doi: 10.1111/resp.13915. Epub 2020 Jul 29.
Nano-mediated strategy for targeting and treatment of non-small cell lung cancer (NSCLC).
Ashique S, Garg A, Mishra N, Raina N, Ming LC, Tulli HS, Behl T, Rani R, Gupta M.
Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):2769-2792. doi: 10.1007/s00210-023-02522-5. Epub 2023 May 23.
